B2M and neoplasm: Although cytoplasmic staining of β2M has been demonstrated in some cases of human renal cell carcinoma (Nomura et al, 2006), here, we highlight the changes in β2M localisation from plasma membrane to cytoplasm between normal and tumour stages of OCSCC.